Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for Arrowhead Pharmaceuticals (ARWR) over the last 9 years, with Sep 2025 value amounting to -$0.18.

  • Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) rose 86.86% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.08, marking a year-over-year increase of 98.40%. This contributed to the annual value of -$0.01 for FY2025, which is 99.80% up from last year.
  • As of Q3 2025, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.18, which was up 85.71% from -$1.26 recorded in Q2 2025.
  • Arrowhead Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $2.75 for Q1 2025, and its period low was -$1.39 during Q4 2024.
  • For the 3-year period, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.60, with its median value being -$1.02 (2024).
  • In the last 5 years, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 326.67% in 2024 and then soared by 369.61% in 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.60 in 2021, then spiked by 35.00% to -$0.39 in 2022, then plummeted by 217.95% to -$1.24 in 2023, then dropped by 12.10% to -$1.39 in 2024, then soared by 86.86% to -$0.18 in 2025.
  • Its last three reported values are -$0.18 in Q3 2025, -$1.26 for Q2 2025, and $2.75 during Q1 2025.